Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Melissa M Meighan"'
Publikováno v:
Stroke. 53
Background: In 2020, a large integrated healthcare system consisting of 21 stroke centers implemented IV tenecteplase as the first line pharmaceutical treatment for acute ischemic stroke (AIS) prior to universal adoption in national clinical practice
Autor:
Mai N Nguyen-huynh, Janet Alexander, Melissa M Meighan, Catherine Lee, Molly Burnett, Vivek A Rao, Sunil Bhopale, Joeffrey R Hatton, Hemali Sudhalkar, Jeffrey Klingman
Publikováno v:
Stroke. 53
Background: Published data suggests tenecteplase (TNKase) is non-inferior to alteplase for acute ischemic stroke treatment. TNKase has certain advantages over alteplase including single-bolus administration. We evaluated TNKase performance in all acu
Autor:
Xian Nan Tang, Jeffrey Klingman, Mai N. Nguyen-Huynh, Janet G. Alexander, David R. Vinson, Melissa M Meighan, Molly Burnett, Stephen Sidney, Alexander C. Flint
Publikováno v:
Stroke
Stroke, vol 51, iss 10
Stroke, vol 51, iss 10
Supplemental Digital Content is available in the text.
Background and Purpose: Shelter-in-place (SIP) orders implemented to mitigate severe acute respiratory syndrome coronavirus 2 spread may inadvertently discourage patient care-seeking behavio
Background and Purpose: Shelter-in-place (SIP) orders implemented to mitigate severe acute respiratory syndrome coronavirus 2 spread may inadvertently discourage patient care-seeking behavio
Autor:
Vivek A. Rao, Alexander C. Flint, Melissa M Meighan, Jeffrey Klingman, Molly Burnett, Mai N. Nguyen-Huynh, Janet G. Alexander, Catherine Lee
Publikováno v:
Stroke. 52
Background: Published data suggest that treating qualified acute strokes within the extended window (EW) or 6-24 hours of last seen normal with endovascular therapy (EST) is associated with better 90-day outcome. In a real-world multi-ethnic practice
Publikováno v:
Stroke. 52
Background: Stroke patients have high rates of all-cause rehospitalization at 30 days (7-24%) and within one year (30-62%). Limited information is available on how to predict these outcomes. We assessed two existing predictive models and whether addi
Autor:
Mai N. Nguyen-Huynh, Melissa M Meighan, Noelani C Warren, Barbara A Schumacher Finnegan, Jorge Lipiz, Stacey E. Alexeeff, Meghan Hatfield
Publikováno v:
Perm J
Introduction Dysphagia occurs in up to 50% of patients with acute stroke symptoms, resulting in increased aspiration pneumonia rates and mortality. The purpose of this study was to validate a health system's dysphagia (swallow) screening tool used si
Autor:
Jeffrey Klingman, Melissa M Meighan, Alexander C. Flint, Catherine Lee, Janet G. Alexander, Mai N. Nguyen-Huynh
Publikováno v:
Stroke. 51
Background: Published data suggest that the faster acute stroke patients are treated with IV alteplase the better they do post discharge. It is not clear that reducing door-to-needle (DTN) time by 15 minutes (from 60 to 45 to 30) is associated with b
Autor:
Alexander C. Flint, Mai N. Nguyen-Huynh, Melissa M Meighan, Jeffrey Klingman, Janet G. Alexander, Catherine Lee
Publikováno v:
Stroke. 51
Background: Risks and benefits of thrombectomy in elderly stroke patients remained unclear. We evaluated outcomes in the elderly who underwent endovascular therapy (EST) in a large integrated healthcare system. Methods: In 2016, our integrated health
Publikováno v:
Stroke. 51
Background and Purpose: Increasing knowledge of pertinent aspects of stroke disease may improve outcomes for stroke survivors and family members. Patients and families are educated in a large integrated health system on Joint Commission required elem
Publikováno v:
Journal of Neuroscience Nursing. 49:31-36
Background and purpose The approved treatment by the Food and Drug Administration for acute ischemic stroke is intravenous tissue-type plasminogen activator (IV tPA). After IV tPA administration, patients are monitored for adverse events using an Ame